Auckland brain implant start-up Kitea Health has closed an over-subscribed funding round at $13 million, co-founder and chief executive Professor Simon Malpas says.
The firm is also on track to begin human trials in the US, following the completion of its first round of human trials, conducted at Auckland Hospital...
Read the full article here.
A practical look at why Design for Manufacture is critical in medtech, and how early consideration of manufacturing, regulatory and commercial requirements can help innovators reduce risk and successfully scale medical devices
NZ Medtech Scene
Yaara Yarmut, Chief Regulatory Officer at Alimetry, explains how early planning can reduce redesign, avoid wasted investment and help ensure MedTech products meet user, market and regulatory needs
.jpg)
NZ Medtech Scene
Design and manufacturing in Medtech doesn’t always fit neatly within a single industry box. Some of the strongest solutions come from bringing in expertise from other sectors like design and manufacturing.